A B S T R A C T The effect of thyroid hormone on maturation of fetal rabbit lung was studied with maternal treatment using 3,5-dimethyl-3'-isopropyl-Lthyronine (DIMIT), a synthetic analogue of triiodothyronine. To investigate the in vivo kinetics and distribution of DIMIT, we prepared [3H]DIMIT and injected both pregnant rats (18-21 d gestation) and rabbits (25 d gestation). In the rat, maximal concentrations of radioactivity in maternal plasma, fetal plasma, and amniotic fluid occurred within 10 min, 1-2 h, and 4-6 h, respectively, after intramuscular injection. After 7 h the concentration of radioactivity in fetal plasma was 163 and 71% of the maternal level in rats and rabbits, respectively, indicating that DIMIT readily crosses the placenta.
minces and phospholipid content of lavage fluid were substantially greater than what had occurred with an optimal dose of betamethasone.
DIMIT also increased corticosteroid binding capacity in fetal plasma and produced a dose-dependent increase (maximal threefold) in total and free corticoids of both maternal and fetal plasma. It is estimated that elevated endogenous corticoids probably account for less than one-third of the increases in phospholipid synthesis and secretion observed at the higher doses of DIMIT.
These data indicate that administration of DIMIT to pregnant rabbits accelerates maturation of the surfactant system in fetal lung. The magnitude of the effects on phospholipid synthesis and secretion, along with the minimal effect on PAPase activity in fetal lung tissue, suggest that thyroid hormones affect different biochemical processes from those influenced by glucocorticoids. INTRODUCTION Hyaline membrane disease in premature infants is associated with deficient amounts of pulmonary surfactant, the phospholipid-protein material that normally prevents atelectasis. The well-documented stimulation of surfactant synthesis by corticosteroids (2) has prompted studies of other hormones that could accelerate lung development. In 1973, Wu et al. (3) reported that itn utero administration thyroxine (T4)' to fetal rabbits enhanced lung maturation as judged by lung lavage and morphologic studies. Comparable morphologic effects were also described in a preliminary report by Rooney and co-workers (4). Smith and Torday (5) reported that T4, like corticosteroids, increased the rate of choline incorporation into lecithin by fetal rabbit lung cells in culture. In fetal sheep, Erenberg et al. (6) found that thyroidectomy was associated with a lower tracheal fluid lecithin:sphingomyelin ratio and immature lung morphology. Two studies of newborn human infants found lower cord plasma triiodothyronine (T3) and T4 levels associated with hyaline membrane disease (7, 8) , and there is one report of accelerated lung development after intra-amniotic administration of T4 to human fetuses (9) . Recently, we identified high affinity binding sites for thyroid hormones in nuclei of fetal rabbit lung and cultured lung cells (10) . These various observations are consistent with the proposal that the fetal lung is a direct target tissue for thyroid hormones.
Because iodothyronines do not readily cross the placenta in most species (11) , studies with T3 and T4 require surgery and direct injection into the fetus. However, this approach apparently introduces stressrelated factors, inasmuch as previous reports indicate that surgery and injection of the rabbit fetus with saline increases plasma corticoids and stimulates phospholipid synthesis (12) (13) (14) (15) (16) . The limited passage of T3 and T4 from mother to fetus also limits any potential application of these hormones in the human for treating fetal hypothyroidism or pulmonary immaturity.
In contrast to T3 and T4, the thyroid hormone analogue 3,5-dimethyl-3'-isopropyl-L-thyronine (DIMIT) is weakly bound by plasma thyroxine-binding globulin (17) and appears to readily cross the placenta in the rat (18) (19) (20) (21) . DIMIT is the most potent of the nonhalogenated thyronine analogues, exhibiting -20% the activity of T4 in the tadpole (22) and rat antigoiter (18) assays. In a recent study, Comite et al. (19) found that administration of DIMIT to pregnant rats, at doses which were not thyrotoxic to the mother, suppressed fetal thyrotropin levels and prevented propylthiouracilinduced fetal goiter. T4 and T3 also prevented fetal goiter, but only in doses that caused maternal hyperthyroidism. Benson et al. (20) reported that treatment of pregnant rats with DIMIT increased the activity of fetal, but not maternal, liver T3 aminotransferase activity, whereas maternal treatment with T3 had opposite effects. Kriz et al. (21) found that administration of DIMIT to pregnant rats caused precocious maturation of both subcellular structure and enzyme activities in fetal liver. These studies indicate that maternally administered DIMIT is thyromimetic in the fetal rat. In addition, they suggest a preferential effect of DIMIT in the fetal compartment.
In this study we have used DIMIT to examine the effects of thyroid hormone on fetal lung maturation. We studied the kinetics and distribution of pH]DIMIT in pregnant animals, and investigated the effects of maternal DIMIT treatment on growth, plasma corticoids, liver biochemical parameters, and synthesis and secretion of pulmonary phospholipids in fetal rabbits.
METHODS

Materials
DIMIT was synthesized as described (18) and dissolved immediately before use at a concentration of 1 mg/ml in sterile 0.9% saline containing 0.02 N NaOH and 10% ethanol (diluent).
[3H]DIMIT (-104 mCi/mmol) was prepared by high energy tritium exchange with the procedure of Hembree et al. (23) and was stored at a concentration of 25 Ag/ml in methanol at -20°C. Before injection, samples were taken to dryness under N2 and redissolved in the same volume of diluent. Betamethasone ether, the fetuses removed, and samples of amniotic fluid, maternal blood (cardiac puncture), and fetal blood (decapitation) were taken in heparinized tubes. In one experiment, serial samples of maternal blood were obtained using the procedure of Upton (24) except for placement of the catheter in the carotid artery. Catheters were also placed in two pregnant New Zealand White rabbits of 25 d gestation, and serial blood samples were taken before and after injection of [3H]DIMIT (-90 ,tg). After 7 h the animals were killed with pentobarbital intravenously, and samples of blood and amniotic fluid were obtained as described above. Radioactivity in samples of plasma and amniotic fluid was determined by scintillation counting. In some experiments we extracted samples of fluid with 5 (25) . Assays were performed on lung tissue from four to eight fetuses per litter, and residual tissue from each litter was pooled for assay of glycogen (26) , protein (27) , DNA (28) , phospholipid (29) , and saturated phosphatidylcholine (30) . In some experiments, fetal liver was assayed for glycogen, and for glucose-6-phosphatase (31) and NADPH cytochrome c reductase (32) in microsomal preparations (21) .
In a second set of experiments, we sacrificed pregnant rabbits at 27 d gestation (control and DIMIT-treated) and at 30.5-31 d (control) for lavage of fetal lungs. Lungs were washed in situ through a tracheal cannula with seven aliquots of 0.7-2.6 ml 0.9% saline. The washings from each litter (generally eight fetuses) were combined and centrifuged for 8 min at 700 g at 2°C to remove cells. Supemate was divided to provide duplicate samples which were centrifuged at 2°C for 150 min at 78,000g. Pellets were resuspended in water, a portion was frozen for assay of PAPase activity,3 and lipids were extracted from the remainder by the method of Folch et al. (33) . Phospholipid phosphorus was assayed by a modification of the method of Baginski and Zak (34) . Phospholipid composition was determined in pooled samples using two dimensional thin-layer chromatography (35) and the osmium tetroxide method of Mason et al. (30) . After lavage, fetal lungs were dried for 72 h at 90°C under vacuum, and phospholipid and PAPase values were calculated per gram dry lung.
Studies in plasma. Plasma corticoids were assayed by competitive protein binding using charcoal adsorbant as described (36) . DIMIT is inactive in this assay. The fraction of corticoids bound to corticosteroid binding globulin (CBG) was measured in 0.1 ml undiluted plasma using charcoal adsorption (36) , and CBG capacity was estimated by the same method after addition of 60 ng cortisol to plasma samples. Albumin was assayed by the dye-binding procedure of Doumas et al. (37) . Free (unbound) corticoids were calculated from the above values as described by Tait and Bumstein (38 3,5-Dimethyl-3 '-Isopropyl-L-Thyronine and Fetal Lung Development
To examine for metabolism of [3H]DIMIT in vivo, maternal and fetal plasma samples from the studies described above were extracted with butanol and the extracts analyzed by thin-layer chromatography. Recovery of radioactivity in butanol was 71 and 79%, and 63 and 62%, in maternal and fetal plasma of rat and rabbit, respectively, compared to 80% for control plasma with added [3H]DIMIT. On thin-layer chromatography the amount of radioactivity migrating with nonradioactive DIMIT was identical for maternal and fetal samples (61% for rat and 100% for rabbit).
This suggests that 60-80% of the plasma radioactivity represents unmetabolized DIMIT, and that the proportion of radioactivity caused by authentic DIMIT is the same in maternal and fetal compartments ofeach species.
DIMIT effects in fetal rabbit tissues. Treatment of pregnant rabbits with 1 mg/kg DIMIT for 2 d did not affect fetal viability, birthweight, lung weight or water content at 26 d gestation (Table II) . The crownrump length of treated fetuses was slightly greater with this dose of DIMIT, however, no effect on length was apparent at DIMIT doses of 0.5 or 3 mg/kg, nor in 27-d gestation fetuses receiving 1 mg/kg DIMIT. There was no apparent effect of treatment on the mothers.
In fetal liver, DIMIT treatment for 2 (21) . There was no effect of DIMIT on the specific activity of glucose-6-phosphatase, whereas an increase occurred in fetal rats treated for 5 d (21) .
In fetal lung tissue, glycogen content in 26-d gestation, DIMIT-treated fetuses was 1.10±0.08 mg/mg DNA compared to 1.76±0.11 (P < 0.05) in control fetuses. There was no effect of treatment on DNA, protein, or tissue phospholipid levels. Values in 
Values are given as mean±SE with number of litters shown in parentheses.
* P < 0.05 compared to control.
3,5-Dimethyl-3'-Isopropyl-L-Thyronine and Fetal Lung Development To examine the specificity of this effect, we measured the levels of plasma albumin. The concentration in DIMIT-treated fetuses (n = 28) was 1.51+0.03 g/dl, which was not significantly different from the mean control value (n = 20) of 1.49+0.05 g/dl. We also assayed CBG capacity in fetuses exposed to betamethasone, and found no effect of this treatment.
These findings are consistent with increased production of CBG, presumably in the fetal liver, after exposure to DIMIT. The increased binding of plasma corticoids by CBG would reduce the concentration of free steroid and potentially could provide a stimulus for compensatory increased secretion of adrenal CBG Copocity (,ug /dl) 10 O I (30) ( (8) (41) . Fig. 3 shows the concentration of total and free corticoids in plasma of 26-d gestation fetuses after various doses of DIMIT. There was a linear increase in both total and free corticoids with increasing doses of DIMIT; at 3 mg/kg DIMIT, total and free values were 3.5 and 3.3 times the control levels, respectively. Treatment with 1 mg/kg DIMIT for 24 h produced somewhat lower corticoid concentrations compared to 48 h exposure (P < 0.05). Similar effects were found at 27 d of gestation; mean concentrations of total plasma corticoids in fetuses receiving diluent and two doses of 1 mg/kg DIMIT were 0.5±0.04 (n = 54), and 1.5+0.08 (n = 74, P < 0.001) ,ug/dl, respectively.
The elevation of both total and free corticoids with DIMIT treatment suggested increased production of corticoids beyond that resulting from increased CBG binding. To evaluate the possible contribution from the maternal adrenal, we assayed corticoids in maternal plasma. At 26 d gestation, total corticoids in animals receiving diluent and 1/0.5 and 3/1.5 mg/kg DIMIT were 1.6±0.3 (n = 9), 3.4+0.6 (n = 4, P < 0.025), and 5.2±1.6 ug/dl (n = 4, P < 0.025), respectively. 3 Plosmo Corticoids (pg/dI) 2 there was no increase in corticoids in three samples obtained during the first 2.5 h after injection. At 24 h, before the second dose of DIMIT, the levels were 5.6 and 4.3 Ag/dl, and they remained elevated at 48 h. In one animal receiving diluent there was no change in serial corticoid values.
The relationship between fetal plasma corticoids and PAPase activity in fetal lung homogenate is presented in Fig. 4 . There is a direct and significant correlation between corticoid levels and PAPase activity in rabbits exposed to diluent, DIMIT, surgery with saline or prolactin injections (15), or betamethasone (25) . This finding supports the proposal that higher doses of DIMIT increase PAPase activity indirectly through elevation of endogenous corticoids.
DISCUSSION
A role for thyroid hormones in fetal lung maturation is suggested by their well-known developmental effects in many organ systems, the increase in plasma T3 and T4 during late fetal life (11), the presence of nuclear T3 receptors in fetal lung (10) , and reported effects of thyroid hormones on the fetal lung (3-6). In the study by Wu 3,5-Dimethyl-3'-Isopropyl-L-Thyronine and Fetal Lung Developmentably because of limited transfer of hormone to the fetus. Similarly, in studies with fetal rats, maternal treatment with T3 was without effect in the fetus except at doses that produced maternal hyperthyroidism (19, 20) . Although direct injection of rabbit fetuses with T4 enhanced pulmonary development (3, 4) , this approach is complicated by stimulatory effects of surgery and injection alone (12) (13) (14) (15) (16) . We felt that maternally administered DIMIT would avoid the complications of surgery and provide a better assessment of thyroid hormone effects in lung maturation.
Previous studies of DIMIT effects in fetal rats suggested that DIMIT freely crossed the placenta (19) (20) (21) (42) . The kinetics of radioactivity clearance from both compartments in rats indicated at least three components, and appeared to be slower in the fetus than in the mother. At the one dose investigated, clearance of DIMIT from plasma ofthe rat appears to be slower than reported for T3 (43) . A relatively slow clearance of DIMIT apparently also occurs in adult humans (44) . The combination of higher concentrations and slower clearance of DIMIT from the fetal circulation of the rat would favor preferential effects of DIMIT in the fetus. In the studies with hypothyroid pregnant rats (19, 20) (16, 25) .
During normal development in the fetal rabbit, the rate of choline incorporation into phosphatidylcholine by fetal lung slices increases approximately fourfold from days 25-26 to 28-29 (16) . We found that treatment with various doses of DIMIT increased choline incorporation by 24 to 104% at 26 d gestation. The increase of 104% with 3 mg/kg DIMIT was nearly double the stimulation seen with optimal doses of betamethasone in our previous study (25) . These findings suggest that DIMIT treatment causes a precocious increase in the rate of phosphatidylcholine synthesis, presumably by stimulating the biosynthetic capacity in fetal lung tissue. However, it is also possible that changes in the size of substrate pools might be a factor. DIMIT decreased the glycogen content of fetal lung by 38%, which is similar to the amount of depletion seen with betamethasone (16) . Wu et al. (3) also noted decreased glycogen by microscopy after in utero T4 injections. These observations support the possibility that pulmonary glycogen provides substrate for phospholipid synthesis during both accelerated and normal development, and suggest that the effect of both thyroid and adrenocortical hormones on phospholipid synthesis may in part result from increased supply of glucose and other substrates.
Glucocorticoids have been reported to stimulate the activities of several enzymes of phospholipid biosynthesis in fetal rabbit lung, however, in most instances the effect remains controversial (2) . We previously reported (25) that betamethasone increases the activity of microsomal PAPase in fetal lung (Table  III) , and this effect was confirmed by Rooney et al (16) . The stimulation of PAPase by betamethasone was closely associated in regard to dosage and timecourse with the increase in rate of choline incorporation (25) . By contrast, treatment with DIMIT produced a relatively small increase in tissue PAPase activity, and only at higher doses of DIMIT administered over 2 d. Thus, the effects of DIMIT on PAPase and choline incorporation are not closely related with regard to either dosage or time-course. The longer interval required for an increase in PAPase activity suggests an indirect and secondary effect of DIMIT on this enzyme. These findings are consistent with a scheme whereby DIMIT acts directly in fetal lung to stimulate phosphatidylcholine synthesis, at a biochemical site not involving PAPase, and also enhances the production and release of corticosteroids through effects elsewhere in the fetus and/or mother. The eventual rise in endogenous plasma corticoids would then induce PAPase in the fetal lung. If glucocorticoids and thyroid hormones do act through different biochemical mechanisms to stimulate phospholipid synthesis, then it is possible that administration of both hormones together would produce an additive effect. This proposal is supported by the reported interaction of steroids and T3 in other systems (46) (47) (48) (49) .
DIMIT treatment increased the content of total phospholipid in lavage by >150%, compared to a 50% increase with 0.1 mg/kg betamethasone. Rooney et al. (16) also found a 50% increase in total phospholipid with 0.2 mg/kg betamethasone. DIMIT also increased the amount of both saturated phosphatidylcholine (+330%) and PAPase activity (+134%) in lavage fluid, indicating an increased amount of surface active material in alveolar spaces.
An increase in plasma corticoids was not anticipated before initiating the study, however, such an effect was suggested by the increase in PAPase activity of lung homogenate after treatment with DIMIT. The corticoid increase was not a stress response to injections; control animals received the same volume of diluent and no immediate increase in corticoids was observed in two animals receiving DIMIT. Administration of T4 to suckling rat pups increases both stressed and basal levels of total corticosterone after 4 and 9 d treatment, respectively (50); this increase apparently results from enhanced levels of CBG (41) . Although plasma CBG increased in DIMITtreated fetuses, this should not in itself result in higher levels of "free" corticoids (41) . In humans, hyperthyroidism increases both the turnover rate and the secretion rate of cortisol, but does not affect plasma levels (51) . Regardless of the mechanism, it is likely that DIMIT acts in the mother, since the percentage of increase in corticoid levels was similar in fetal and maternal circulation. DIMIT may also act directly in the fetus, however, fetal effects alone should not produce an equivalent percentage increase in maternal plasma corticoids.
The rise in endogenous fetal corticoids raises the question as to their role in the effects observed with DIMIT treatment. Several lines of evidence indicate that DIMIT has actions in the fetus that are independent of steroid effects. The increase of both liver NADPH cytochrome c reductase activity and plasma CBG capacity are presumably direct effects of DIMIT, since neither reductase activity (45) nor CBG levels in the fetus are influenced by glucocorticoids. In fetal lung, lower doses of DIMIT markedly increased choline incorporation without affecting the activity of PAPase, an enzyme which is apparently responsive to both exogenous and endogenous glucocorticoids. Finally, the increase in both choline incorporation and lavage phospholipid with DIMIT treatment was significantly greater than occurred with optimal doses of betamethasone.
On the other hand, it is likely that endogenous corticoids contribute to the effects observed in fetal lung at higher doses of DIMIT. With the 1 and 3 mg/kg regimens of DIMIT, PAPase activity in lung homogenate increased 11 and 38%, respectively, presumably as a result of the higher plasma corticoid levels. Because the stimulation of PAPase activity by betamethasone is similar in magnitude to the effect observed on choline incorporation (25) , it may be estimated that endogenous corticoids account for less than one-third of the increase in rate of choline incorporation after DIMIT treatment. Similarly in lavage fluid, based on the effect observed with betamethasone, endogenous corticoids would appear to account for one-third or less ofthe increase in phospholipid content seen with DIMIT. A direct mode of action by DIMIT is also supported by the previous observation that T4 stimulates the rate of choline incorporation by fetal rabbit lung cells in culture (5) . These considerations strongly suggest that most of the effects observed with DIMIT are mediated by a mechanism independent of glucocorticoids.
We have previously proposed that DIMIT and other thyroid hormones may act via nuclear receptors in fetal lung to induce enzymes involved in the synthesis of surfactant (10) . This study suggests that thyroid hormone affects enzyme(s) different from those stimulated by glucocorticoids. If this is the case, corticosteroids and thyroid hormones may have complementary and additive effects on lung maturation. DIMIT will be useful in exploring this possibility further. Moreover, thyroid hormone analogues of this type may eventually find application in prenatal prevention of hyaline menmbrane disease in human infants.
